Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-positive breast cancer, the HER2 (human epidermal growth factor receptor 2) gene doesn?t work correctly and makes too many copies of itself. These extra HER2 genes make too many proteins known as HER2 receptors.Anti-HER2 medicines attach to the HER2 receptor proteins on the surface of breast cancer cells.Anti-HER2 medicines work by blocking the HER2 receptors from receiving the growth signals in HER2-positive breast cancer. By blocking the growth signals, anti-HER2 medicines can slow or stop the growth of HER2-positive and HER2-low breast cancer. Anti-HER2 medicines only work on HER2-positive and HER2-low breast cancer. They do not work on HER2-negative breast cancer.
This report contains market size and forecasts of Anti-HER2 Therapy in Global, including the following market information:
Global Anti-HER2 Therapy Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global top five companies in 2022 (%)
The global Anti-HER2 Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Anti-HER2 Monoclonal Antibodies Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Anti-HER2 Therapy include GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, Sanofi, Merck, Glenmark Pharmaceuticals and Roche, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-HER2 Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-HER2 Therapy Market, by Type, 2018-2023, 2023-2032 ($ millions)
Global Anti-HER2 Therapy Market Segment Percentages, by Type, 2022 (%)
Anti-HER2 Monoclonal Antibodies
Antibody-Drug Conjugate
Kinase Inhibitors
Global Anti-HER2 Therapy Market, by Application, 2018-2023, 2023-2032 ($ millions)
Global Anti-HER2 Therapy Market Segment Percentages, by Application, 2022 (%)
Online Pharmacy
Retail Pharmacy
Medical Clinics
Global Anti-HER2 Therapy Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions)
Global Anti-HER2 Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-HER2 Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-HER2 Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Merck
Glenmark Pharmaceuticals
Roche
Novartis
Astra Zeneca
Daiichi Sankyo
Celltrion
Teva
Biocon
Viatris
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-HER2 Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-HER2 Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-HER2 Therapy Overall Market Size
2.1 Global Anti-HER2 Therapy Market Size: 2022 VS 2032
2.2 Global Anti-HER2 Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-HER2 Therapy Players in Global Market
3.2 Top Global Anti-HER2 Therapy Companies Ranked by Revenue
3.3 Global Anti-HER2 Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti-HER2 Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-HER2 Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-HER2 Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anti-HER2 Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-HER2 Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anti-HER2 Therapy Market Size Markets, 2022 & 2032
4.1.2 Anti-HER2 Monoclonal Antibodies
4.1.3 Antibody-Drug Conjugate
4.1.4 Kinase Inhibitors
4.2 By Type - Global Anti-HER2 Therapy Revenue & Forecasts
4.2.1 By Type - Global Anti-HER2 Therapy Revenue, 2018-2023
4.2.2 By Type - Global Anti-HER2 Therapy Revenue, 2023-2032
4.2.3 By Type - Global Anti-HER2 Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-HER2 Therapy Market Size, 2022 & 2032
5.1.2 Online Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Medical Clinics
5.2 By Application - Global Anti-HER2 Therapy Revenue & Forecasts
5.2.1 By Application - Global Anti-HER2 Therapy Revenue, 2018-2023
5.2.2 By Application - Global Anti-HER2 Therapy Revenue, 2023-2032
5.2.3 By Application - Global Anti-HER2 Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Anti-HER2 Therapy Market Size, 2022 & 2032
6.2 By Region - Global Anti-HER2 Therapy Revenue & Forecasts
6.2.1 By Region - Global Anti-HER2 Therapy Revenue, 2018-2023
6.2.2 By Region - Global Anti-HER2 Therapy Revenue, 2023-2032
6.2.3 By Region - Global Anti-HER2 Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Anti-HER2 Therapy Revenue, 2018-2032
6.3.2 US Anti-HER2 Therapy Market Size, 2018-2032
6.3.3 Canada Anti-HER2 Therapy Market Size, 2018-2032
6.3.4 Mexico Anti-HER2 Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Anti-HER2 Therapy Revenue, 2018-2032
6.4.2 Germany Anti-HER2 Therapy Market Size, 2018-2032
6.4.3 France Anti-HER2 Therapy Market Size, 2018-2032
6.4.4 U.K. Anti-HER2 Therapy Market Size, 2018-2032
6.4.5 Italy Anti-HER2 Therapy Market Size, 2018-2032
6.4.6 Russia Anti-HER2 Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Anti-HER2 Therapy Market Size, 2018-2032
6.4.8 Benelux Anti-HER2 Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Anti-HER2 Therapy Revenue, 2018-2032
6.5.2 China Anti-HER2 Therapy Market Size, 2018-2032
6.5.3 Japan Anti-HER2 Therapy Market Size, 2018-2032
6.5.4 South Korea Anti-HER2 Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Anti-HER2 Therapy Market Size, 2018-2032
6.5.6 India Anti-HER2 Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Anti-HER2 Therapy Revenue, 2018-2032
6.6.2 Brazil Anti-HER2 Therapy Market Size, 2018-2032
6.6.3 Argentina Anti-HER2 Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-HER2 Therapy Revenue, 2018-2032
6.7.2 Turkey Anti-HER2 Therapy Market Size, 2018-2032
6.7.3 Israel Anti-HER2 Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Anti-HER2 Therapy Market Size, 2018-2032
6.7.5 UAE Anti-HER2 Therapy Market Size, 2018-2032
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Anti-HER2 Therapy Major Product Offerings
7.1.4 GlaxoSmithKline Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Anti-HER2 Therapy Major Product Offerings
7.2.4 Bayer Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Anti-HER2 Therapy Major Product Offerings
7.3.4 Abbott Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Anti-HER2 Therapy Major Product Offerings
7.4.4 AbbVie Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.4.5 AbbVie Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Anti-HER2 Therapy Major Product Offerings
7.5.4 Pfizer Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Anti-HER2 Therapy Major Product Offerings
7.6.4 Sanofi Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Anti-HER2 Therapy Major Product Offerings
7.7.4 Merck Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.7.5 Merck Key News
7.8 Glenmark Pharmaceuticals
7.8.1 Glenmark Pharmaceuticals Corporate Summary
7.8.2 Glenmark Pharmaceuticals Business Overview
7.8.3 Glenmark Pharmaceuticals Anti-HER2 Therapy Major Product Offerings
7.8.4 Glenmark Pharmaceuticals Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.8.5 Glenmark Pharmaceuticals Key News
7.9 Roche
7.9.1 Roche Corporate Summary
7.9.2 Roche Business Overview
7.9.3 Roche Anti-HER2 Therapy Major Product Offerings
7.9.4 Roche Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.9.5 Roche Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Anti-HER2 Therapy Major Product Offerings
7.10.4 Novartis Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News
7.11 Astra Zeneca
7.11.1 Astra Zeneca Corporate Summary
7.11.2 Astra Zeneca Business Overview
7.11.3 Astra Zeneca Anti-HER2 Therapy Major Product Offerings
7.11.4 Astra Zeneca Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.11.5 Astra Zeneca Key News
7.12 Daiichi Sankyo
7.12.1 Daiichi Sankyo Corporate Summary
7.12.2 Daiichi Sankyo Business Overview
7.12.3 Daiichi Sankyo Anti-HER2 Therapy Major Product Offerings
7.12.4 Daiichi Sankyo Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.12.5 Daiichi Sankyo Key News
7.13 Celltrion
7.13.1 Celltrion Corporate Summary
7.13.2 Celltrion Business Overview
7.13.3 Celltrion Anti-HER2 Therapy Major Product Offerings
7.13.4 Celltrion Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.13.5 Celltrion Key News
7.14 Teva
7.14.1 Teva Corporate Summary
7.14.2 Teva Business Overview
7.14.3 Teva Anti-HER2 Therapy Major Product Offerings
7.14.4 Teva Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.14.5 Teva Key News
7.15 Biocon
7.15.1 Biocon Corporate Summary
7.15.2 Biocon Business Overview
7.15.3 Biocon Anti-HER2 Therapy Major Product Offerings
7.15.4 Biocon Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.15.5 Biocon Key News
7.16 Viatris
7.16.1 Viatris Corporate Summary
7.16.2 Viatris Business Overview
7.16.3 Viatris Anti-HER2 Therapy Major Product Offerings
7.16.4 Viatris Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.16.5 Viatris Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-HER2 Therapy Market Opportunities & Trends in Global Market
Table 2. Anti-HER2 Therapy Market Drivers in Global Market
Table 3. Anti-HER2 Therapy Market Restraints in Global Market
Table 4. Key Players of Anti-HER2 Therapy in Global Market
Table 5. Top Anti-HER2 Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-HER2 Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-HER2 Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-HER2 Therapy Product Type
Table 9. List of Global Tier 1 Anti-HER2 Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-HER2 Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2023-2032
Table 14. By Application ? Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2023-2032
Table 17. By Region ? Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Anti-HER2 Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-HER2 Therapy Revenue (US$, Mn), 2023-2032
Table 20. By Country - North America Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-HER2 Therapy Revenue, (US$, Mn), 2023-2032
Table 22. By Country - Europe Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-HER2 Therapy Revenue, (US$, Mn), 2023-2032
Table 24. By Region - Asia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-HER2 Therapy Revenue, (US$, Mn), 2023-2032
Table 26. By Country - South America Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-HER2 Therapy Revenue, (US$, Mn), 2023-2032
Table 28. By Country - Middle East & Africa Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-HER2 Therapy Revenue, (US$, Mn), 2023-2032
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Anti-HER2 Therapy Product Offerings
Table 32. GlaxoSmithKline Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Bayer Corporate Summary
Table 34. Bayer Anti-HER2 Therapy Product Offerings
Table 35. Bayer Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Abbott Corporate Summary
Table 37. Abbott Anti-HER2 Therapy Product Offerings
Table 38. Abbott Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Anti-HER2 Therapy Product Offerings
Table 41. AbbVie Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Anti-HER2 Therapy Product Offerings
Table 44. Pfizer Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Anti-HER2 Therapy Product Offerings
Table 47. Sanofi Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 48. Merck Corporate Summary
Table 49. Merck Anti-HER2 Therapy Product Offerings
Table 50. Merck Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Glenmark Pharmaceuticals Corporate Summary
Table 52. Glenmark Pharmaceuticals Anti-HER2 Therapy Product Offerings
Table 53. Glenmark Pharmaceuticals Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Roche Corporate Summary
Table 55. Roche Anti-HER2 Therapy Product Offerings
Table 56. Roche Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Novartis Corporate Summary
Table 58. Novartis Anti-HER2 Therapy Product Offerings
Table 59. Novartis Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 60. Astra Zeneca Corporate Summary
Table 61. Astra Zeneca Anti-HER2 Therapy Product Offerings
Table 62. Astra Zeneca Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Daiichi Sankyo Corporate Summary
Table 64. Daiichi Sankyo Anti-HER2 Therapy Product Offerings
Table 65. Daiichi Sankyo Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Celltrion Corporate Summary
Table 67. Celltrion Anti-HER2 Therapy Product Offerings
Table 68. Celltrion Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 69. Teva Corporate Summary
Table 70. Teva Anti-HER2 Therapy Product Offerings
Table 71. Teva Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 72. Biocon Corporate Summary
Table 73. Biocon Anti-HER2 Therapy Product Offerings
Table 74. Biocon Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
Table 75. Viatris Corporate Summary
Table 76. Viatris Anti-HER2 Therapy Product Offerings
Table 77. Viatris Anti-HER2 Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Anti-HER2 Therapy Segment by Type in 2022
Figure 2. Anti-HER2 Therapy Segment by Application in 2022
Figure 3. Global Anti-HER2 Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-HER2 Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Anti-HER2 Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-HER2 Therapy Revenue in 2022
Figure 8. By Type - Global Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 10. By Region - Global Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 11. By Country - North America Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 12. US Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 13. Canada Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 14. Mexico Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 15. By Country - Europe Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 16. Germany Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. France Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. U.K. Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. Italy Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 20. Russia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. Nordic Countries Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. Benelux Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. By Region - Asia Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 24. China Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Japan Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. South Korea Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. Southeast Asia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 28. India Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. By Country - South America Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 30. Brazil Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Argentina Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. By Country - Middle East & Africa Anti-HER2 Therapy Revenue Market Share, 2018-2032
Figure 33. Turkey Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 34. Israel Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Saudi Arabia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. UAE Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2032
Figure 37. GlaxoSmithKline Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Bayer Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Abbott Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. AbbVie Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Pfizer Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Glenmark Pharmaceuticals Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Astra Zeneca Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Daiichi Sankyo Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Celltrion Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Teva Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Biocon Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Viatris Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
